RichardMBergenstalMD

Endocrinology • Minneapolis, MN

Diabetes, Lipid Metabolism

Executive Director, International Diabetes Center

Join to view full profile

Dr. Bergenstal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bergenstal's full profile

Already have an account?

Office
3800 Park Nicollet Blvd
Minneapolis, MN 55416
Phone+1 952-993-1913
Is this information wrong?

Education & Training

University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1982
University of ChicagoResidency, Internal Medicine, 1976 - 1979
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1976

Certifications & Licensure

MN State Medical License 1983 - 2024
IL State Medical License 1977 - 1984
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes Start of enrollment: 2004 Sep 01
Completed
Phase 4
Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes Start of enrollment: 2006 Jan 01
Completed
Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM Data Start of enrollment: 2006 Apr 01
Completed
Glucose Meter Study Start of enrollment: 2008 Nov 01
Completed
Not Applicable
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide Start of enrollment: 2006 Dec 01
Completed
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control Start of enrollment: 2008 Apr 01
Completed
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine Start of enrollment: 2010 Apr 01
Completed
Not Applicable
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes Start of enrollment: 2010 Jun 01
Completed
Not Applicable
Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia Start of enrollment: 2010 Aug 01
Completed
Phase 4
Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes Start of enrollment: 2010 Oct 01
Completed
Not Applicable
Blood Glucose Monitoring System Clinical Study Start of enrollment: 2010 Dec 01
Completed
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP) Start of enrollment: 2014 Mar 01
Completed
Not Applicable
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
Fuzzy Logic Automated Insulin Regulation Start of enrollment: 2019 Jun 03
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

2 citations
Update on Measuring Ketones.
Jingtong Huang, Andrea M Yeung, Richard M Bergenstal, Kristin Castorino, Eda Cengiz, Ketan Dhatariya, Isabella Niu, Jennifer L Sherr, Guillermo E Umpierrez, David C Kl...> ;Journal of Diabetes Science and Technology. 2023 Feb 16
7 citations
Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes.
Viral N Shah, Tim Vigers, Laura Pyle, Peter Calhoun, Richard M Bergenstal> ;Diabetes Technology & Therapeutics. 2023 May 1
Primary Care and Diabetes Technologies and Treatments.
Gregg D Simonson, Thomas W Martens, Anders L Carlson, Richard M Bergenstal> ;Diabetes Technology & Therapeutics. 2023 Feb 1
86 citations
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
Tadej Battelino, Charles M Alexander, Stephanie A Amiel, Guillermo Arreaza-Rubin, Roy W Beck, Richard M Bergenstal, Bruce A Buckingham, James Carroll, Antonio Ceriello...> ;The Lancet. Diabetes & Endocrinology. 2023 Jan 1
The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring.
Roy W Beck, Dan Raghinaru, Peter Calhoun, Richard M Bergenstal> ;Diabetes Technology & Therapeutics. 2023 Mar 1
2 citations
A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes.
Maamoun Salam, Ryan Bailey, Peter Calhoun, Janet B McGill, Richard M Bergenstal, David Price, Roy W Beck> ;Diabetes Technology & Therapeutics. 2023 Mar 1
8 citations
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomi...
Tadej Battelino, Thomas Danne, Steve V Edelman, Pratik Choudhary, Eric Renard, Jukka Westerbacka, Bhaswati Mukherjee, Valerie Pilorget, Mathieu Coudert, Richard M Berg...> ;Diabetes, Obesity & Metabolism. 2023 Feb 1
4 citations
Assessment of the Glucose Management Indicator Using Different Sampling Durations.
Ryan Bailey, Peter Calhoun, Richard M Bergenstal, Roy W Beck> ;Diabetes Technology & Therapeutics. 2023 Feb 1
20 citations
Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association fo...
Jennifer L Sherr, Lutz Heinemann, G Alexander Fleming, Richard M Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W Holl, John R Petrie, Anne L Peters, Mark E...> ;Diabetologia. 2023 Jan 1
11 citations
Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association fo...
Jennifer L Sherr, Lutz Heinemann, G Alexander Fleming, Richard M Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W Holl, John R Petrie, Anne L Peters, Mark E...> ;Diabetes Care. 2022 Dec 1
77 citations
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
Moshe Phillip, Revital Nimri, Richard M Bergenstal, Katharine Barnard-Kelly, Thomas Danne, Roman Hovorka, Boris P Kovatchev, Laurel H Messer, Christopher G Parkin, Lou...> ;Endocrine Reviews. 2023 Mar 4
4 citations
Impact of Temporary Glycemic Target Use in the Hybrid and Advanced Hybrid Closed-Loop Systems.
Klemen Dovc, Tadej Battelino, Roy W Beck, Judy Sibayan, Ryan J Bailey, Peter Calhoun, Christine Turcotte, Stuart Weinzimer, Darja Smigoc Schweiger, Revital Nimri, Rich...> ;Diabetes Technology & Therapeutics. 2022 Nov 1
3 citations
The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial.
Dan Raghinaru, Peter Calhoun, Richard M Bergenstal, Roy W Beck> ;Diabetes Technology & Therapeutics. 2022 Dec 1
8 citations
A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G.
Stuart A Weinzimer, Ryan J Bailey, Richard M Bergenstal, Revital Nimri, Roy W Beck, Desmond Schatz, Louise Ambler-Osborn, Darja Smigoc Schweiger, Thekla von dem Berge,...> ;Diabetes Technology & Therapeutics. 2022 Aug 1
17 citations
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (S...
Tadej Battelino, Richard M Bergenstal, Angel Rodríguez, Laura Fernández Landó, Ross Bray, Zhentao Tong, Katelyn Brown> ;The Lancet. Diabetes & Endocrinology. 2022 Jun 1
7 citations
Interindividual variability in average glucose-glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice.
Yongjin Xu, Richard M Bergenstal, Timothy C Dunn, Yashesvini Ram, Ramzi A Ajjan> ;Diabetes, Obesity & Metabolism. 2022 Sep 1
8 citations
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino, ...> ;Cardiovascular Diabetology. 2022 Apr 8
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care...
Ryan Bailey, Peter Calhoun, Roy W Beck, Richard M Bergenstal, Grazia Aleppo> ;Diabetes Care. 2022 Apr 1
Primary Care and Diabetes Technologies and Treatments.
Gregg D Simonson, Thomas W Martens, Anders L Carlson, Richard M Bergenstal> ;Diabetes Technology & Therapeutics. 2022 Mar 1
12 citations
Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study.
Rose A Gubitosi-Klug, Barbara H Braffett, Ionut Bebu, Mary L Johnson, Kaleigh Farrell, David Kenny, Victoria R Trapani, Lynne Meadema-Mayer, Elsayed Z Soliman, Rodica ...> ;Diabetes Care. 2022 Mar 1
19 citations
Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes.
Richard M Bergenstal, Deborah M Mullen, Ellie Strock, Mary L Johnson, Min X Xi> ;Journal of Diabetes and Its Complications. 2022 Mar 1
A Safe and Simple Algorithm for Adding and Adjusting Mealtime Insulin to Basal-Only Therapy.
Mary L Johnson, Richard M Bergenstal, Brian L Levy, Darlene M Dreon> ;Clinical Diabetes. 2022 Jan 1
11 citations
Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk f...
Ronald Goldenberg, Vanita R. Aroda, Liana K. Billings, A. Sia Louise Christiansen, Anders Meller Donatsky, Ehsan Parvaresh Rizi, Gracjan Podgorski, Katarina Raslova, D...> ;Diabetes, Obesity & Metabolism. 2021 Nov 1
5 citations
More Green, Less Red: How Color Standardization May Facilitate Effective Use of CGM Data.
Richard M. Bergenstal, Gregg D. Simonson, Lutz Heinemann> ;Journal of Diabetes Science and Technology. 2021 Oct 28
8 citations
Real-World, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes Using the MiniMed 670G Hybrid Closed-Loop System.
Stephanie N. DuBose, Colleen Bauza, Alandra Verdejo, Roy W. Beck, Richard M. Bergenstal, Jennifer L. Sherr> ;Diabetes Technology & Therapeutics. 2021 Oct 28
Join now to see all

Journal Articles

Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
James R Gavin, Yogish C Kudva, Richard M Bergenstal, Davida F Kruger, Journal of the Endocrine Society

Lectures

Continuous Glucose Monitoring Systems: Uses and Abuses
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
Cardiometabolic Health Congress (CMHC 2012)
Cardiometabolic Health Congress, Boston, Massachusetts - 10/10/2012
Glucose Variability (Dysglycemia) and Diabetes Complications--Does It Matter? (Con)
Richard M. Bergenstal, MD - 6/14/2014

Press Mentions

Latest Data Shows That Most People with Diabetes Don’t Meet Glucose Targets. What Can Be Done? (ADA 2021)June 30th, 2021
American Diabetes Association, June 12-16June 21st, 2020
Abbott, Medtronic Go Head-to-Head at ADA ConferenceJune 15th, 2020
Join now to see all

Professional Memberships

American Association of Clinical Endocrinologists - AACE
Member

Hospital Affiliations

Park Nicollet Methodist HospitalMinneapolis, Minnesota
St. Cloud VA Medical CenterSaint Cloud, Minnesota